AWM
LKFT

Altium Wealth Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Altium Wealth Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,120
Closed -$418K – 344
2020
Q2 		$418K Buy
2,120
+615
+41% +$127K 0.05% 212
2020
Q1 		$295K Buy
+1,505
New +$324K 0.04% 216

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Altium Wealth Management's LKFT Position: Q3 2020 in Review

Altium Wealth Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 2,120 shares — an estimated $418K sold.

Altium Wealth Management first reported a position in LKFT in Q1 2020 and held it in 2 quarters. The position peaked at $418K in Q2 2020. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

  • Altium Wealth Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Altium Wealth Management sold 2,120 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $418K.
  • Altium Wealth Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and held it in 2 quarters.
  • Altium Wealth Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $418K in Q2 2020.
  • 119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Altium Wealth Management's 13F filing for Q3 2020, filed 26 Oct 2020.